Get started
Author

Madeleine Crabtree

Observed name: M. Crabtree
ORCID: 0000-0001-5310-6595
Observed ORCID: 0000-0001-5310-6595
OpenAlex ID: A5040787380
Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)
2020 · Luis Querol, M. Crabtree, et al. · Journal of Neurology · 110
PDF
Burden of illness in chronic inflammatory demyelinating polyneuropathy: some clarifications
2020 · L. Querol, M. Crabtree, et al. · Journal of Neurology · 5
Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting
2025 · Gil L'Italien, Basia Rogula, et al. · Parkinsonism & Related Disorders · 3
PDF
Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC
2025 · Jürgen Wolf, Sarah Goring, et al. · Cancers · 3
Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease
2025 · Gil L’Italien, Basia Rogula, et al. · Neurology and Therapy · 2
PDF
PCR192 Content Validity of the EQ-5D and Health Utilities Index (HUI) to Assess Health-Related Quality-of-Life (HRQoL) Impact in Duchenne Muscular Dystrophy (DMD)
2023 · S. Szabo, I. Filipovic Audhya, et al. · Value in Health · 2
PDF
Re-weighting MDS-UPDRS Parts II and III Items to Improve Assessment of Motor Decline in Untreated Parkinson’s Disease (P7-5.014)
2025 · Samuel Dickson, Basia Rogula, et al. · Neurology · 1
69PClinically important improvements in adults with late-onset Pompe disease switching from alglucosidase alfa to cipaglucosidase alfa plus miglustat
2025 · K. Claeys, H. Kushlaf, et al. · Neuromuscular Disorders
Re-weighting MDS-UPDRS Part II and PDQ-39 Items to Detect Maximal Decline in Activities of Daily Living in Untreated Parkinson’s disease (P7-5.015)
2025 · Gilbert L’Italien, Samuel Dickson, et al. · Neurology
P-576. Real-world Experience with the Two-Drug Regimen Dolutegravir/Lamivudine for the Treatment of HIV-1 among Vulnerable People Living with HIV in Canada: Preliminary Results from a Chart Review Study
2025 · Emmanuelle Huchet, Joann K Ban, et al. · Open Forum Infectious Diseases
PDF
EE119 Development of a De Novo Model to Assess the Cost-Effectiveness of a New Treatment Option for Patients With Primary Immunoglobulin a Nephropathy (IgAN)
2023 · N. Davies, O. Dickinson, et al. · Value in Health
PDF
Pro68 a Systematic Literature Review of the Burden of Illness in Chronic Inflammatory Demyelinating Polyneuropathy
2019 · M. Crabtree, M. Herepath, et al. · Value in Health
PDF
Works count: 12
Citation count: 126
H-index: 3
I10-index: 1
Year
Topic
Type